REPL
Replimune Group, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -1.7% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +2 | 45.55M | $503.98M | +13 | −11 |
| Q1 2026 | 75 | +4 | 41.32M | $315.89M | +10 | −6 |
| Q4 2025 | 71 | +3 | 45.45M | $441.76M | +3 | — |
| Q3 2025 | 15 | -4 | 32.26M | $135.16M | — | −4 |
| Q2 2025 | 16 | 0 | 29.86M | $277.39M | — | — |
| Q1 2025 | 13 | 0 | 20.78M | $202.64M | — | — |
| Q4 2024 | 13 | +1 | 19.63M | $237.78M | +2 | −1 |
| Q3 2024 | 11 | +1 | 14.48M | $158.71M | +1 | — |
| Q2 2024 | 10 | — | 16.01M | $144.07M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.82M | -0.3% | $100.51M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 2 | BlackRock ✦ (passive) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 3 | The Vanguard Group ✦ (passive) | 3.47M | — | $32.23M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (passive) | 2.45M | +2.3% | $22.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 1.87M | -25.0% | $17.34M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 6 | Geode Capital Management ✦ (passive) | 1.62M | -2.9% | $15.09M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 944.51K | +0.9% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 8 | Millennium Management ✦ | 794.05K | -35.1% | $7.38M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 712.54K | +642.4% | $6.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 506.60K | -36.4% | $4.71M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 11 | Fidelity (FMR) ✦ | 391.66K | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Citadel Advisors ✦ | 277.47K | +1119.4% | $2.58M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 153.09K | -2.0% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 81.95K | 0.0% | $761,306 | 0.0% | Held | 5 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 22.42K | -49.5% | $208,291 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 12.21K | -7.8% | $113,450 | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 178 holders, 80.31M shares, $547.04M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 9.26K sh · $132,176
Officer · 11.45K sh · $148,481
Officer, Director · 39.34K sh · $510,253
Officer · 7.63K sh · $98,987
Officer · 11.45K sh · $148,468
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
11.8% of class · View original SEC filing ↗